Hagen Cramer is a notable inventor based in West Chester, Ohio. He has made significant contributions to the field of oligonucleotide manufacturing. His innovative approach has led to the development of a unique process that enhances the efficiency of oligonucleotide production.

Latest Patents

Cramer holds a patent for a process for the manufacture of oligonucleotides. This process involves the removal of β-eliminating phosphorus-protecting groups, particularly β-cyanoethyl protective groups from a protected oligonucleotide. The method includes contacting the protected oligonucleotide with an amine solution in a solvent that preferably does not consist of pyridine. The conjugate acid of the amine has a pKa of greater than 11.5, and the concentration of the amine in the solution is less than 0.5 mole/liters. This patent showcases Cramer's innovative approach to improving oligonucleotide synthesis.

Career Highlights

Cramer is currently employed at Nitto Denko Avecia, Inc., where he continues to work on advancements in the field of biotechnology. His expertise in oligonucleotide manufacturing has positioned him as a valuable asset to his company and the industry at large.

Collaborations

Cramer has collaborated with several talented individuals in his field, including Tadeusz Krzysztof Wyrzykiewicz and Huihe Zhu. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Hagen Cramer is a distinguished inventor whose work in oligonucleotide manufacturing has made a significant impact on the biotechnology industry. His innovative processes and collaborations highlight his commitment to advancing scientific research and development.

Profile summary based on public USPTO records.